| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |